Research and Development

Showing 15 posts of 9607 posts found.

Sanofi Pasteur MSD appoints new UK medical director

August 17, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Sanofi Pasteur MSD has appointed Dr Aidrian Kilcoyne as medical director in the UK. He joins the company from Roche …

Contract research news in brief

August 17, 2011 Research and Development research and development news

Our round-up of news from the contract research sector includes the rejection of a cancer drug by the FDA because …

How the best labs manage talent

August 16, 2011 Business Services, Manufacturing and Production, Research and Development careers, recruitment, talent retention

Of the $1.2 trillion spent globally each year on R&D across corporations and academia, 40 per cent – much the …

Onyx Scientific bought by India’s Ipca Labs

August 16, 2011 Manufacturing and Production, Research and Development Ipca, Onyx, contract research news, pharma manufacturing news, research and development news

India’s Ipca Laboratories has bought UK chemistry services firm Onyx Scientific for around £4.6 million ($7.5m). The Mumbai-based company, a …

New head of oncology for Astellas Pharma Europe

August 16, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Astellas Pharma has appointed Dr Christopher Thomson as executive director of its new European Oncology Unit.   Dr Thomson will …
GlaxoSmithKline

GSK Parkinson’s drug shows motor skills benefits

August 16, 2011 Research and Development GSK, Impax Pharmaceuticals, Parkinson's disease, research and development news

GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …

Afrezza could breathe new life into inhaled insulin market

August 15, 2011 Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news

New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …

Study shows new genetic risk factors for MS

August 15, 2011 Research and Development genes, multiple sclerosis, research and development news

New genetic links to the immune system have been identified as a possible trigger for multiple sclerosis. The exact causes …

Nanoparticles to target Alzheimer’s disease

August 10, 2011 Research and Development Alzheimer's, nanoparticles

Researchers at Lancaster University funded by the European Union are hoping to develop a new treatment for Alzheimer’s disease. Nanoparticles …

New MS drug shows promise for Abbott

August 10, 2011 Research and Development, Sales and Marketing Abbott, Avonex, Biogen, MS, gilenya

Biogen and Abbott’s multiple sclerosis drug daclizumab has performed well in a mid-stage trial, but two deaths marred the overall …

Pfizer teams up with University of California for drug discovery

August 9, 2011 Research and Development, Sales and Marketing Pfizer, academic research

Pfizer has signed a deal with the University of California to help expand its drug discovery and development programme. The …

Takeda and Amylin stop obesity trial

August 8, 2011 Research and Development, Sales and Marketing Amylin, Takeda

Takeda and Amylin have decided to halt further studies of its combination treatment for obesity, due to ‘evolving dynamics’ within …
Pfizer building

Biotica becomes new victim of Pfizer’s R&D downsizing

August 8, 2011 Research and Development, Sales and Marketing

Pfizer has pulled out of a $195 million deal with UK firm Biotica, as it continues to downsize its global …

Meet Wainwright Associates at the TOPRA Symposium and CPhl worldwide

August 7, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Wainwright Associates is an independent company offering consultancy services to the pharmaceutical, medical device and healthcare industry in Product Development, …

Mergers and spending cuts damaging drug research

August 3, 2011 Research and Development, Sales and Marketing LaMattina, Pfizer, research productivity

Big pharma’s policy of mergers and swingeing cuts is having a devastating effect on drug research, says a former Pfizer …
The Gateway to Local Adoption Series

Latest content